Advances in the drug therapies of acute myeloid leukemia (except acute promyelocytic leukemia)
Min Lin, Baoan Chen Department of Hematology and Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People’s Republic of China Abstract: Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy ...
Chen B, Lin M
core
A Case of Acute Myeloid Leukemia, Myelodysplasia-Related (AML-MR) with Immunophenotypic Features Suggestive of B/Myeloid Mixed-Phenotype Acute Leukemia (MPAL), Harboring Multiple <i>KMT2A</i> Gene Amplifications. [PDF]
Łączak J +8 more
europepmc +1 more source
Acute myeloid leukemia with unusual mature lymphoid-like morphology in a subset of blasts. [PDF]
Vossen C, E Jordan C.
europepmc +1 more source
Editorial: Biomarkers and precision medicine in myeloid neoplasms. [PDF]
Datta Mitra A.
europepmc +1 more source
From transcriptomic profiling to precision oncology: a bibliometric analysis of RNA sequencing in acute myeloid leukemia. [PDF]
Ren Y, Ma J, Hu W, Zhang L, Wang X.
europepmc +1 more source
Venetoclax with azacitidine and dexamethasone: Non-cytotoxic induction therapy for T-cell leukemia and mixed-phenotype leukemia. [PDF]
Lei Y +11 more
europepmc +1 more source
Prediction model for survival outcome in patients with acute myeloid leukemia: a multicenter prospective cohort study from Thai Acute Leukemia Working Group. [PDF]
Saelue P +15 more
europepmc +1 more source
Identification of ultrasound-associated gene candidates in myeloid cells and construction of a prognostic risk model for acute myeloid leukemia. [PDF]
Zhu L, Dai Y.
europepmc +1 more source
Does disease ontogeny matter more than JAK2 mutation status in acute myeloid leukemia? [PDF]
Babu NS, Sangeetha KSS.
europepmc +1 more source

